Yin Guo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yin Guo

Showing results (241-250 of 243) with videos related to

Pageof 25

Sort By:

You have reached the last page of results.This site can display upto 243 results.

Journal of Medicinal Chemistry|May 2, 2024

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2Yunhang Guo, Hai Xue, Nan Hu, et al.

Journal of Medicinal Chemistry|March 13, 2023

Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune DiseasesYunhang Guo, Nan Hu, Ye Liu, et al.

Journal of Medicinal Chemistry|August 6, 2019

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseYunhang Guo, Ye Liu, Nan Hu, et al.

Pageof 25

Search research articles

Showing results (241-250 of 243) with videos related to

Sort By:

Pageof 25

You have reached the last page of results.This site can display upto 243 results.

Journal of Medicinal Chemistry|May 2, 2024

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2Yunhang Guo, Hai Xue, Nan Hu, et al.

Journal of Medicinal Chemistry|March 13, 2023

Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune DiseasesYunhang Guo, Nan Hu, Ye Liu, et al.

Journal of Medicinal Chemistry|August 6, 2019

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseYunhang Guo, Ye Liu, Nan Hu, et al.

Pageof 25